BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22966967)

  • 21. Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones.
    Simonov M; Abel EA; Skanderson M; Masoud A; Hauser RG; Brandt CA; Wilson FP; Laine L
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):72-79.e21. PubMed ID: 32147588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study.
    Chen CB; Lin M; Eurich DT; Johnson JA
    Clin Ther; 2016 Jun; 38(6):1392-1400. PubMed ID: 27061884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
    MacLaren R; Kassel LE; Kiser TH; Fish DN
    Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of spontaneous bacterial peritonitis associated with gastric Acid suppression.
    Chang SS; Lai CC; Lee MG; Lee YC; Tsai YW; Hsu WT; Lee CC
    Medicine (Baltimore); 2015 Jun; 94(22):e944. PubMed ID: 26039135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
    Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients.
    Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS
    Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
    Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
    BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
    Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
    Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
    J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    Park SK; Nam JH; Lee H; Chung H; Lee EK; Shin JY
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2135-2143. PubMed ID: 31145825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case-control study.
    Miyano S; Michihata N; Sada KE; Uda K; Matsui H; Fushimi K; Nangaku M; Yasunaga H
    Rheumatology (Oxford); 2021 Apr; 60(4):1717-1723. PubMed ID: 33067623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
    Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
    Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women's Health Initiative.
    Ballinger TJ; Djuric Z; Sardesai S; Hovey KM; Andrews CA; Brasky TM; Zhang JT; Rohan TE; Saquib N; Shadyab AH; Simon M; Wactawski-Wende J; Wallace R; Kato I
    Nutr Cancer; 2023; 75(1):265-275. PubMed ID: 35968582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin use and infections in Veterans with cirrhosis.
    Motzkus-Feagans C; Pakyz AL; Ratliff SM; Bajaj JS; Lapane KL
    Aliment Pharmacol Ther; 2013 Sep; 38(6):611-8. PubMed ID: 23889738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
    Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
    Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
    Tan MC; El-Serag HB; Yu X; Thrift AP
    Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Hung TH; Lee HF; Tseng CW; Tsai CC; Tsai CC
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):353-359. PubMed ID: 29551615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
    Poulsen AH; Christensen S; McLaughlin JK; Thomsen RW; Sørensen HT; Olsen JH; Friis S
    Br J Cancer; 2009 May; 100(9):1503-7. PubMed ID: 19352380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.